NEOGENOMICS INC's ticker is and the CUSIP is 64049MAA8. A total of 18 filers reported holding NEOGENOMICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $11,399,000 | -3.0% | 13,650,000 | 0.0% | 0.01% | +22.2% |
| Q1 2022 | $11,749,000 | +406.6% | 13,650,000 | +780.6% | 0.01% | +350.0% |
| Q1 2021 | $2,319,000 | -92.1% | 1,550,000 | -91.6% | 0.00% | -93.1% |
| Q4 2020 | $29,365,000 | -4.0% | 18,415,000 | -24.7% | 0.03% | -19.4% |
| Q3 2020 | $30,590,000 | +70.4% | 24,440,000 | +47.9% | 0.04% | +71.4% |
| Q2 2020 | $17,947,000 | – | 16,525,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opti Capital Management, LP | 15,750,000 | $13,592,000 | 1.09% |
| Context Capital Management, LLC | 13,000 | $11,214,000 | 0.73% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 19,422,000 | $16,659,000 | 0.27% |
| WOLVERINE ASSET MANAGEMENT LLC | 18,386,000 | $15,685,000 | 0.15% |
| Aequim Alternative Investments LP | 3,500,000 | $3,019,000 | 0.08% |
| LINDEN ADVISORS LP | 12,066,000 | $10,358,000 | 0.06% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 23,500,000 | $20,269,000 | 0.06% |
| LAZARD ASSET MANAGEMENT LLC | 15,000,000 | $12,937,000 | 0.02% |
| D. E. Shaw & Co., Inc. | 16,900,000 | $14,517,000 | 0.01% |
| BNP PARIBAS FINANCIAL MARKETS | 10,323,000 | $8,800,358,000 | 0.01% |